NCT04890808View on ClinicalTrials.gov

Therapeutic Antioxidant Supplementation

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2027

Conditions
Superficial Siderosis
Interventions
DIETARY_SUPPLEMENT

Inosine

Patients will be dosed with two 500 mg capsules of Inosine twice daily for 36 months

DIETARY_SUPPLEMENT

IP6

Patients will be dosed with two 500 mg capsules of IP6 twice daily for 36 months

All Listed Sponsors
lead

Superficial Siderosis Research Alliance Inc.

OTHER

NCT04890808 - Therapeutic Antioxidant Supplementation | Biotech Hunter | Biotech Hunter